| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin without any … | |
Heteromer
| 48-423 | 97.32 | 1×MLA; |
|
| Infectious B19V capsid | |
Heteromer
Q6RCN1; | 48-422 | 100.0 | |
|
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I-allo1: an allosterically triggered drug-… | | homo-2-mer | 45-423 | 94.97 | 3×EDO; 1×CL; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | | homo-2-mer | 45-423 | 97.05 | 1×HCY; 5×EDO; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | | homo-2-mer | 45-423 | 97.05 | 1×AS4; 1×EDO; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | | homo-2-mer | 45-423 | 97.05 | 1×STR; 2×EDO; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | | homo-2-mer | 46-423 | 97.04 | 1×C0R; |
|
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I-allo2: a MMP9-cleavable drug-binding ser… | | homo-2-mer | 45-422 | 95.28 | 1×CIT; 1×EDO; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex w… | | homo-2-mer | 46-423 | 97.04 | 1×TES; |
|
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I5: a MMP14-cleavable drug-binding serpin … | | homo-2-mer | 45-422 | 95.82 | 1×PEG; 1×DXT; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-II: a new binding globulin in complex wi… | | homo-2-mer | 46-422 | 97.93 | 2×EDO; 1×HCY; |
|
| Crystal structure of Alpha1-antichymotrypsin variant DBS-II: a drug-binding serpin for doxorubicin | | homo-2-mer | 46-422 | 94.97 | 1×DM2; |
|
| Crystal form 2 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically modulated drug-bin… | | homo-2-mer | 46-422 | 94.64 | 1×CL; 1×EDO; 1×NI; |
|
| CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMP… | | homo-2-mer | 47-423 | 100 | 1×NAG; 1×NAG; 1×PO4; |
|
| Crystal structure of Alpha1-antichymotrypsin variant DBS-I1: a drug-binding serpin for doxycycline | | homo-2-mer | 46-421 | 95.27 | 1×EDO; 1×DXT; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-0: a new binding globulin variant that i… | | homo-2-mer | 48-423 | 98.81 | |
|
| Crystal structure of Alpha1-antichymotrypsin variant DBS-II-allo-L55V: an allosterically controlled… | | homo-2-mer | 48-422 | 94.61 | 4×EDO; |
|
| Crystal form 1 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically modulated drug-bin… | | homo-2-mer | 49-423 | 94.92 | 3×EDO; 1×DM2; |
|
| CLEAVED ANTICHYMOTRYPSIN A349R | | homo-2-mer | 48-422 | 99.7 | 1×ACT; |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-III-allo: an allosterically controlled n… | | homo-2-mer | 49-422 | 96.97 | 3×CL; 3×CA; 2×EDO; |
|
| CLEAVED ANTICHYMOTRYPSIN A347R | | homo-2-mer | 50-421 | 99.7 | |
|
| CLEAVED ANTICHYMOTRYPSIN T345R | | homo-2-mer | 51-422 | 99.7 | |
|
| Crystal structure of Alpha1-antichymotrypsin variant NewBG-I in the uncleaved S-conformation | | monomer | 45-422 | 96.69 | |
|
| Antichymotrypsin | | monomer | 47-423 | 99.72 | |
|
| Infectious B19V capsid | | monomer | 48-422 | 100.0 | |
|
| Alpha1-antichymotrypsin serpin in the delta conformation (partial loop insertion) | | monomer | 49-422 | 99.73 | |
|